Transcatheter Tricuspid Repair Lowers Mortality and Hospitalization Risks

Transcatheter tricuspid valve repair significantly improves clinical outcomes and quality of life for high-risk patients suffering from severe tricuspid regurgitation, according to results presented at the ESC Congress 2026 and published simultaneously in the New England Journal of Medicine. Transcatheter tricuspid valve repair combined with medical therapy significantly cuts heart failure hospitalizations and all-cause death … Read more

AI Sleep Model Uncovers Hidden Health Risks of Apnea

Researchers have developed an artificial intelligence model that decodes neural, cardiac, and respiratory signals from routine sleep studies to identify high-risk patients that conventional apnea measurements miss, according to a study published in Nature Communications. Sleep disorders affect nearly one billion adults globally, making accurate long-risk stratification an urgent priority for healthcare systems. Limitations of … Read more

Planetary Health Diet Lowers Cardiovascular Risk in Older Women

A 20-year study of more than 65,000 postmenopausal women found that higher adherence to the Planetary Health Diet was associated with a lower risk of overall cardiovascular disease, coronary heart disease, stroke, and heart failure, according to findings from the Women’s Health Initiative. Cardiovascular Risk Reduction Among Postmenopausal Women Researchers following 66,892 participants in the … Read more

Updated ABCs Framework for Heart Disease Prevention

The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more

COVID-19 Linked to Long-Term Sleep Apnea Risk

A study published in the journal Scientific Reports reveals that individuals who have contracted SARS-CoV-2 face an increased risk of developing new-onset obstructive sleep apnea (OSA) for up to 4.5 years post-infection. Researchers analyzing electronic medical records from the Montefiore Health System for over 910,000 patients found that COVID-19 infection is independently associated with a … Read more

Lysosomal Protein Prevents Heart Failure by Stabilizing Mitochondria

Researchers have identified the lysosomal ion channel TRPML1 as a critical regulator of mitochondrial stability, offering a potential new therapeutic target to prevent the progression of pathological cardiac hypertrophy into heart failure. A study published in the journal Engineering found that TRPML1 protects heart cells by inhibiting the oligomerization of VDAC1, a protein on the … Read more

Low Blood Pressure Linked to Higher Alzheimer’s Risk

Low blood pressure, or hypotension, is linked to a significantly higher risk of developing Alzheimer’s disease, according to a study published in the Journal of the American Heart Association. Researchers analyzing data from nearly 800,000 adults found that individuals with low blood pressure were up to three times more likely to be diagnosed with Alzheimer’s … Read more

Protein Repair Defects: A Hidden Cause of Heart Failure

Researchers at the Medical University of South Carolina (MUSC) have identified a fundamental defect in the protein repair systems of patients with idiopathic dilated cardiomyopathy (IDCM). According to a 2026 study published in the Journal of Molecular and Cellular Cardiology, this breakdown in cellular maintenance leads to the accumulation of misfolded protein plaques, mirroring processes … Read more

Diabetes Drug Significantly Reduces Heart Failure Risk in Genetic Carriers

New research published in Nature Medicine reveals that the medication dapagliflozin significantly reduces the risk of heart failure in patients who carry specific cardiomyopathy-associated genetic variants. Findings from the Mass General Brigham Heart and Vascular Institute and the Broad Institute of MIT and Harvard suggest that these genetic markers could help clinicians identify patients who … Read more

Why Is No One Taking Baby Aspirin for Heart Disease Prevention Anymore?

The Conclude of the “Baby Aspirin” Era? Why Heart Health is Getting Personal For decades, the daily “baby aspirin” was a staple in the medicine cabinets of millions of older adults. The logic seemed simple: by making blood platelets less sticky, aspirin could theoretically prevent the arterial blockages that lead to heart attacks and strokes. … Read more